# Effect of Itraconazole on the Pharmacokinetics of SHR6390 in Healthy Subjects

> **NCT04423601** · PHASE1 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 18 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** SHR6390 tablet
- **DRUG:** Itraconazole capsule

## Key facts

- **NCT ID:** NCT04423601
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-10
- **Primary completion:** 2020-07-29
- **Final completion:** 2021-02-02
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2021-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04423601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04423601, "Effect of Itraconazole on the Pharmacokinetics of SHR6390 in Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04423601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*